Acute Myocardial Infarction Management
Acute Myocardial infarction (AMI), commonly known as a heart attack, is the irreversible necrosis of heart muscle secondary to prolonged ischemia due to lack of oxygen supply. Most often it is caused by plaque rupture with thrombus formation in a coronary vessel, resulting in an acute reduction of blood supply to a portion of the myocardium. There is an indisputable scientific evidence that percutaneous myocardial revascularisation in patients with acute forms of coronary artery disease is life saving and limits potential disabilities. Hence it has been recommended in the latest AMI management guidelines.
Terumo has long term commitment to optimizing the treatment of Acute Myocardial Infarction with strong scientific and educational support, exceptional product portfolio and exciting new technology.
AMI Newsroom
- Fast, effective, safe: Making the right choices in STEMI patients
- Optical imaging-guidance in STEMI patients treated with primary PCI
- Clinical relevance of bleeding and thrombus burden in high-risk ACS-NSTEMI-patients
Terumo solutions for AMI
Clinical data
NOBORI 2 – AMI / Presented at PCR May 20, 2011, F. Fath-Ordoubadi
NOBORI 2 – ACS/Gender / Presented at PCR May 18, 2012, F. Fath-Ordoubadi
TROFI study / Presented at TCT November 7, 2011, P. W. Serruys
Trans-radial approach as a part of bleeding prevention strategy in STEMI patients
Fast, Effective and Safe: making the right choices in STEMI - Presented at PCR May 17, 2012, M. Valgimigli
Publications
Educational activities
- Seminars on “high-risk” Acute Coronary Syndrome
For further information, please contact your local Terumo representative.